{
    "Trade/Device Name(s)": [
        "In Vitro Nano-Check\u2122 AMI cTnI Cardiac Marker Test"
    ],
    "Submitter Information": "Nano-Ditech Corporation",
    "510(k) Number": "K102131",
    "Predicate Device Reference 510(k) Number(s)": [],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "MMI"
    ],
    "Summary Letter Date": "October 20, 2010",
    "Summary Letter Received Date": "September 21, 2010",
    "Submission Date": "September 16, 2010",
    "Regulation Number(s)": [
        "21 CFR 862.1215"
    ],
    "Regulation Name(s)": [
        "Creatine phosphokinase/creatine kinase or isoenzymes test system"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Cardiac Troponin I (cTnI)"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Plasma"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [
        "Rapid immunoassay"
    ],
    "Methodologies": [],
    "Submission Type(s)": [
        "Assay"
    ],
    "Document Summary": "FDA 510(k) summary for In Vitro Nano-Check AMI cTnI rapid immunoassay for cardiac marker detection in serum and plasma",
    "Indications for Use Summary": "Qualitative determination of cardiac troponin I (cTnI) in human serum and plasma to aid in the diagnosis of acute myocardial infarction (AMI)",
    "fda_folder": "Clinical Chemistry"
}